[ {
  "@graph" : [ {
    "@id" : "http://bio2rdf.org/drugbank:DB06168",
    "@type" : [ "http://bio2rdf.org/drugbank_vocabulary:Drug" ],
    "http://bio2rdf.org/bio2rdf_vocabulary:identifier" : [ {
      "@value" : "DB06168"
    } ],
    "http://bio2rdf.org/bio2rdf_vocabulary:namespace" : [ {
      "@value" : "drugbank"
    } ],
    "http://bio2rdf.org/bio2rdf_vocabulary:uri" : [ {
      "@value" : "http://bio2rdf.org/drugbank:DB06168"
    } ],
    "http://bio2rdf.org/bio2rdf_vocabulary:x-identifiers.org" : [ {
      "@id" : "http://identifiers.org/drugbank/DB06168"
    } ],
    "http://bio2rdf.org/drugbank_vocabulary:drugbank-id" : [ {
      "@value" : "DB06168"
    } ],
    "http://bio2rdf.org/drugbank_vocabulary:x-atc" : [ {
      "@id" : "http://bio2rdf.org/atc:L04AC08"
    } ],
    "http://bio2rdf.org/drugbank_vocabulary:x-cas" : [ {
      "@id" : "http://bio2rdf.org/cas:914613-48-2"
    } ],
    "http://bio2rdf.org/drugbank_vocabulary:x-kegg" : [ {
      "@id" : "http://bio2rdf.org/kegg:D09315"
    } ],
    "http://bio2rdf.org/drugbank_vocabulary:x-ndc" : [ {
      "@id" : "http://bio2rdf.org/ndc:0078-0582-61"
    } ],
    "http://bio2rdf.org/drugbank_vocabulary:x-wikipedia" : [ {
      "@id" : "http://bio2rdf.org/wikipedia:Canakinumab"
    } ],
    "http://purl.org/dc/terms/description" : [ {
      "@language" : "en",
      "@value" : "Canakinumab is a recombinant, human anti-human-IL-1β monoclonal antibody that belongs to the IgG1/κ isotype subclass. It is expressed in a murine Sp2/0-Ag14 cell line and comprised of two 447- (or 448-) residue heavy chains and two 214-residue light chains, with a molecular mass of 145157 Daltons when deglycosylated. Both heavy chains of canakinumab contain oligosaccharide chains linked to the protein backbone at asparagine 298 (Asn 298). Canakinumab binds to human IL-1β and neutralizes its inflammatory activity by blocking its interaction with IL-1 receptors, but it does not bind IL-1alpha or IL-1 receptor antagonist (IL-1ra). Canakinumab is marketed under the brand name Ilaris and indicated for patients 4 years of age and older to treat Familial Cold Autoinflammatory Syndrome (FCAS) and Muckle-Wells Syndrome (MWS), which are both part of the Cryopyrin-Associated Periodic Syndromes (CAPS) as well as for patients 2 years of age and older to treat systemic juvenile idiopathic arthritis (SJIA). Clinical trials have established the administration of canakinumab every 2 weeks to be safe and effective, offering a considerable advantage over the existing treatment with the human IL-1 receptor antagonist, anakinra, which must be injected daily and which is often poorly tolerated by patients."
    } ],
    "http://purl.org/dc/terms/identifier" : [ {
      "@value" : "drugbank:DB06168"
    } ],
    "http://purl.org/dc/terms/title" : [ {
      "@language" : "en",
      "@value" : "Canakinumab"
    } ],
    "http://www.w3.org/2000/01/rdf-schema#label" : [ {
      "@language" : "en",
      "@value" : "Canakinumab [drugbank:DB06168]"
    } ],
    "http://www.w3.org/2000/01/rdf-schema#seeAlso" : [ {
      "@id" : "http://www.drugbank.ca/drugs/DB06168"
    }, {
      "@id" : "http://www.drugs.com/mtm/canakinumab.html"
    }, {
      "@id" : "http://www.rxlist.com/ilaris-drug.htm"
    } ]
  } ],
  "@id" : "http://bio2rdf.org/drugbank:DB06168_nanopub.RARbWoab9yznhxc9KJ1hdBZ3xAUcEIbRU20ek1FHfFSg4#assertion"
}, {
  "@graph" : [ {
    "@id" : "http://bio2rdf.org/drugbank:DB06168_nanopub.RARbWoab9yznhxc9KJ1hdBZ3xAUcEIbRU20ek1FHfFSg4",
    "@type" : [ "http://www.nanopub.org/nschema#Nanopublication" ],
    "http://www.nanopub.org/nschema#hasAssertion" : [ {
      "@id" : "http://bio2rdf.org/drugbank:DB06168_nanopub.RARbWoab9yznhxc9KJ1hdBZ3xAUcEIbRU20ek1FHfFSg4#assertion"
    } ],
    "http://www.nanopub.org/nschema#hasProvenance" : [ {
      "@id" : "http://bio2rdf.org/drugbank:DB06168_nanopub.RARbWoab9yznhxc9KJ1hdBZ3xAUcEIbRU20ek1FHfFSg4#provenance"
    } ],
    "http://www.nanopub.org/nschema#hasPublicationInfo" : [ {
      "@id" : "http://bio2rdf.org/drugbank:DB06168_nanopub.RARbWoab9yznhxc9KJ1hdBZ3xAUcEIbRU20ek1FHfFSg4#publicationInfo"
    } ]
  } ],
  "@id" : "http://bio2rdf.org/drugbank:DB06168_nanopub.RARbWoab9yznhxc9KJ1hdBZ3xAUcEIbRU20ek1FHfFSg4#head"
}, {
  "@graph" : [ {
    "@id" : "http://bio2rdf.org/drugbank:DB06168_nanopub.RARbWoab9yznhxc9KJ1hdBZ3xAUcEIbRU20ek1FHfFSg4#assertion",
    "http://www.w3.org/ns/prov#wasDerivedFrom" : [ {
      "@id" : "http://download.bio2rdf.org/release/3/drugbank/drugbank.nq.gz"
    } ]
  }, {
    "@id" : "http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3",
    "http://www.w3.org/ns/dcat#distribution" : [ {
      "@id" : "http://download.bio2rdf.org/release/3/drugbank/drugbank.nq.gz"
    } ]
  }, {
    "@id" : "http://download.bio2rdf.org/release/3/drugbank/drugbank.nq.gz",
    "http://purl.org/dc/terms/created" : [ {
      "@type" : "http://www.w3.org/2001/XMLSchema#dateTime",
      "@value" : "2015-01-09T17:00:50-05:00"
    } ],
    "http://www.w3.org/ns/prov#wasDerivedFrom" : [ {
      "@id" : "http://www.drugbank.ca/system/downloads/current/drugbank.xml.zip#retrieved-on:2014-11-12T07:57:03-05:00"
    } ]
  }, {
    "@id" : "http://www.drugbank.ca/system/downloads/current/drugbank.xml.zip",
    "http://www.w3.org/ns/prov#wasAttributedTo" : [ {
      "@id" : "http://drugbank.ca"
    } ]
  }, {
    "@id" : "http://www.drugbank.ca/system/downloads/current/drugbank.xml.zip#retrieved-on:2014-11-12T07:57:03-05:00",
    "http://purl.org/pav/retrievedOn" : [ {
      "@type" : "http://www.w3.org/2001/XMLSchema#dateTime",
      "@value" : "2014-11-12T07:57:03-05:00"
    } ],
    "http://www.w3.org/ns/prov#wasDerivedFrom" : [ {
      "@id" : "http://www.drugbank.ca/system/downloads/current/drugbank.xml.zip"
    } ]
  } ],
  "@id" : "http://bio2rdf.org/drugbank:DB06168_nanopub.RARbWoab9yznhxc9KJ1hdBZ3xAUcEIbRU20ek1FHfFSg4#provenance"
}, {
  "@graph" : [ {
    "@id" : "http://bio2rdf.org/drugbank:DB06168_nanopub.RARbWoab9yznhxc9KJ1hdBZ3xAUcEIbRU20ek1FHfFSg4",
    "http://purl.org/dc/terms/created" : [ {
      "@type" : "http://www.w3.org/2001/XMLSchema#dateTime",
      "@value" : "2018-03-30T11:11:03.984+02:00"
    } ],
    "http://purl.org/dc/terms/license" : [ {
      "@id" : "https://creativecommons.org/licenses/by-nc/4.0/"
    } ],
    "http://purl.org/nanopub/x/hasSignatureElement" : [ {
      "@id" : "http://bio2rdf.org/drugbank:DB06168_nanopub.RARbWoab9yznhxc9KJ1hdBZ3xAUcEIbRU20ek1FHfFSg4#signature.MCwCFCQebn0LSME-"
    } ],
    "http://www.w3.org/ns/prov#wasGeneratedBy" : [ {
      "@id" : "https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.7720f136-841b-4851-a6e4-ad20a409a475"
    } ]
  }, {
    "@id" : "http://bio2rdf.org/drugbank:DB06168_nanopub.RARbWoab9yznhxc9KJ1hdBZ3xAUcEIbRU20ek1FHfFSg4#signature.MCwCFCQebn0LSME-",
    "http://purl.org/nanopub/x/hasPublicKey" : [ {
      "@value" : "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"
    } ],
    "http://purl.org/nanopub/x/hasSignature" : [ {
      "@value" : "MCwCFCQebn0LSME+pbxSSc0nVLNOOxPjAhQK/UxtUbAvERC3Ft9AtmTRJX0p4w=="
    } ],
    "http://purl.org/nanopub/x/signedBy" : [ {
      "@id" : "https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB"
    } ]
  }, {
    "@id" : "https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB",
    "http://www.w3.org/ns/prov#specializationOf" : [ {
      "@id" : "https://github.com/tkuhn/bio2rdf2nanopub"
    } ],
    "http://www.w3.org/ns/prov#wasAttributedTo" : [ {
      "@id" : "http://orcid.org/0000-0002-1267-0234"
    } ]
  }, {
    "@id" : "https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.7720f136-841b-4851-a6e4-ad20a409a475",
    "http://purl.org/dc/terms/identifier" : [ {
      "@value" : "7720f136-841b-4851-a6e4-ad20a409a475"
    } ],
    "http://www.w3.org/ns/prov#used" : [ {
      "@id" : "https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349"
    } ],
    "http://www.w3.org/ns/prov#wasAssociatedWith" : [ {
      "@id" : "https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB"
    } ],
    "http://www.w3.org/ns/prov#wasStartedBy" : [ {
      "@id" : "http://orcid.org/0000-0002-1267-0234"
    } ]
  }, {
    "@id" : "https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349",
    "http://purl.org/dc/terms/isVersionOf" : [ {
      "@id" : "https://github.com/tkuhn/bio2rdf2nanopub"
    } ],
    "http://purl.org/pav/version" : [ {
      "@value" : "eda7951a5f6c622c5d2132f50c3093138484a349"
    } ],
    "http://www.w3.org/ns/prov#wasAttributedTo" : [ {
      "@id" : "http://orcid.org/0000-0002-1267-0234"
    } ]
  } ],
  "@id" : "http://bio2rdf.org/drugbank:DB06168_nanopub.RARbWoab9yznhxc9KJ1hdBZ3xAUcEIbRU20ek1FHfFSg4#publicationInfo"
} ]